EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases

G E Wensink iD, Karen Bolhuis, Marloes A G Elferink, Remond J A Fijneman, Onno Kranenburg, Inne H M Borel Rinkes, Miriam Koopman iD, Rutger-Jan Swijnenburg, Geraldine R Vink, Jeroen Hagendoorn, Cornelis J A Punt, Jeanine M L Roodhart und 1 weitere

British Journal of Surgery · 15.02.2023 · 110 (3) · 362-371

DOI: 10.1093/bjs/znac461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 19.01.2023. Verfasst von G E Wensink und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sacha Swarttouw-Hijmans Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients who develop early extrahepatic recurrence (EHR) may not benefit from local treatment of colorectal liver metastases (CRLMs). This study aimed to develop a prediction model for early EHR after local treatment of CRLMs using a national data set.

Methods

A Cox regression prediction model for EHR was developed and validated internally using data on patients who had local treatment for CRLMs with curative intent. Performance assessment included calibration, discrimination, net benefit, and generalizability by internal–external cross-validation. The prognostic relevance of early EHR (within 6 months) was evaluated by landmark analysis.

Results

During a median follow-up of 35 months, 557 of the 1077 patients had EHR and 249 died. Median overall survival was 19.5 (95 per cent c.i. 15.6 to 23.0) months in patients with early EHR after CRLM treatment, compared with not reached (45.3 months to not reached) in patients without an early EHR. The EHR prediction model included side and stage of the primary tumour, RAS/BRAFV600E mutational status, and number and size of CRLMs. The range of 6-month EHR predictions was 5.9–56.0 (i.q.r. 12.9–22.0) per cent. The model demonstrated good calibration and discrimination. The C-index through 6 and 12 months was 0.663 (95 per cent c.i. 0.624 to 0.702) and 0.661 (0.632 to 0.689) respectively. The observed 6-month EHR risk was 6.5 per cent for patients in the lowest quartile of predicted risk compared with 32.0 per cent in the highest quartile.

Conclusion

Early EHR after local treatment of CRLMs can be predicted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsHumansPrognosisNeoplasm Recurrence, LocalHepatectomyRetrospective Studies

Autor:innen und Institutionen

  • Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
  • Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Surgery, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.

ORCID-Profile: G E Wensink, Miriam Koopman

Förderung

  • Sacha Swarttouw-Hijmans Fund

Zitieren

APA

Wensink, G. E., Bolhuis, K., Elferink, M. A. G., Fijneman, R. J. A., Kranenburg, O., Borel Rinkes, I. H. M., Koopman, M., Swijnenburg, R. J., Vink, G. R., Hagendoorn, J., Punt, C. J. A., Roodhart, J. M. L., & Elias, S. G. (2023). Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases. British Journal of Surgery, 110(3), 362-371. https://doi.org/10.1093/bjs/znac461

Vancouver

Wensink GE, Bolhuis K, Elferink MAG, Fijneman RJA, Kranenburg O, Borel Rinkes IHM, et al. Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases. British Journal of Surgery. 2023;110(3):362-371. doi:10.1093/bjs/znac461

BibTeX
@article{Wensink2023,
  author = {Wensink, G E and Bolhuis, Karen and Elferink, Marloes A G and Fijneman, Remond J A and Kranenburg, Onno and Borel Rinkes, Inne H M and Koopman, Miriam and Swijnenburg, Rutger-Jan and Vink, Geraldine R and Hagendoorn, Jeroen and Punt, Cornelis J A and Roodhart, Jeanine M L and Elias, Sjoerd G},
  title = {Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases},
  journal = {British Journal of Surgery},
  year = {2023},
  volume = {110},
  number = {3},
  pages = {362--371},
  doi = {10.1093/bjs/znac461}
}
Kostenlos starten →